doi:10.3969/j.issn.1673-8640.2016.02.008

Abstract

CLC Number:

R446.1

Figures/Tables 1

References 10

[1]	肾性贫血诊断和治疗共识中国专家组.肾性贫血诊断与治疗中国专家共识[J].中华肾脏病杂志,2013,29(5):389-392.
[2]	吴惠玲,张大莲,高晓玲,等.肾性贫血患者网织红细胞参数的变化及临床意义[J].现代诊断与治疗,2008,19(6):324-326.
[3]	苏丽,赵万富,孙延河.网织红细胞水平测定在肾性贫血中的应用[J].国际检验医学杂志,2010,31(8):897.
[4]	唐斌. 外源性EPO治疗肾性贫血患者相关红细胞参数研究[J].现代检验医学杂志,2013,28(5):53-55.
[5]	赵应斌,黎华连,丁燕玲,等.肾性贫血的网织红细胞 6 项参数分析[J].实用医学杂志,2010,26(20):3806-3808.
[6]	BEIRAGHDAR F,PANAHI Y,EINOLLAHI B,et al.Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial[J]. Clin Lab,2012,58(7-8):737-745.
[7]	付新欣,徐承杰. 红细胞参数在慢性肾衰中的应用[J].医学检验与临床,2010,21(4):46-48.
[8]	彭燕,王庆旭,栗群英,等. 肾性贫血患者血清铁蛋白与叶酸检测的临床意义[J].西南国防医药,2011,21(8):863-865.
[9]	SHIBATA M,TANIGUCHI S.Iron supplementation therapy in end-stage renal disease patients on maintenance hemodialysis[J]. Cardiovasc Hematol Disord Drug Targets,2013 ,13(3):237-242.
[10]	ECKHARDT A, FREIBERG MA,DE LA FUENTE J, et al. Clinical usefulness of the reticulocyte hemoglobin equivalent in chronic hemodialysis patients[J]. Rev Fac Cien Med Univ Nac Cordoba,2011,68(2):51-55.

组别	例数	RBC（×10¹²/L）			Hb（g/L）			HCT（%）		MCV（fL）		MCH（pg）
RA组	30	2.36±0.42			73.13±11.02			22.93±3.31		98.28±7.70^**		31.34±2.69^**
非RA组	30	2.82±0.77			72.67±11.28			23.48±3.74		86.00±12.20		26.83±4.76
组别	MCHC（g/L）			RDW-SD（fL）			RDW-CV（%）				RET#（×10¹²/L）	RET%（%）
RA组	318.9±12.1			48.82±6.31			14.41±1.68^*				0.04±0.02^**	1.89±1.07^*
非RA组	310.8±18.9			45.90±7.65			15.67±2.88				0.08±0.04	2.99±2.18
组别	HFR（%）		MFR（%）			LFR（%）			IRF（%）
RA组	0.76±1.01		6.80±4.29			92.41±4.64^*			7.59±4.64^*
非RA组	1.30±1.88		9.28±5.27			89.43±6.48			10.57±6.48

组别	例数	RBC（×10¹²/L）			Hb（g/L）			HCT（%）		MCV（fL）		MCH（pg）
RA组	30	2.36±0.42			73.13±11.02			22.93±3.31		98.28±7.70^**		31.34±2.69^**
非RA组	30	2.82±0.77			72.67±11.28			23.48±3.74		86.00±12.20		26.83±4.76
组别	MCHC（g/L）			RDW-SD（fL）			RDW-CV（%）				RET#（×10¹²/L）	RET%（%）
RA组	318.9±12.1			48.82±6.31			14.41±1.68^*				0.04±0.02^**	1.89±1.07^*
非RA组	310.8±18.9			45.90±7.65			15.67±2.88				0.08±0.04	2.99±2.18
组别	HFR（%）		MFR（%）			LFR（%）			IRF（%）
RA组	0.76±1.01		6.80±4.29			92.41±4.64^*			7.59±4.64^*
非RA组	1.30±1.88		9.28±5.27			89.43±6.48			10.57±6.48

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 10

Related Articles 15

Recommended Articles

Metrics